Intrexon Corp (NYSE:XON) shares shot up 16.9% during trading on Tuesday . The company traded as high as $13.49 and last traded at $13.47. 3,850,000 shares were traded during mid-day trading, an increase of 187% from the average session volume of 1,340,000 shares. The stock had previously closed at $11.52.

A number of brokerages have issued reports on XON. Bank of America decreased their target price on shares of Intrexon from $25.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. ValuEngine lowered shares of Intrexon from a “sell” rating to a “strong sell” rating in a research report on Sunday. Stifel Nicolaus increased their target price on shares of Intrexon from $39.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, November 10th. Northland Securities restated a “buy” rating and set a $21.00 target price on shares of Intrexon in a research report on Friday, November 10th. Finally, JMP Securities restated an “outperform” rating and set a $42.00 target price on shares of Intrexon in a research report on Thursday, October 5th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $38.50.

The company has a market capitalization of $1,630.00, a PE ratio of -12.03 and a beta of 1.32. The company has a quick ratio of 1.85, a current ratio of 2.05 and a debt-to-equity ratio of 0.01.

Several large investors have recently made changes to their positions in XON. Steward Partners Investment Advisory LLC acquired a new position in shares of Intrexon during the 3rd quarter worth approximately $121,000. Tower Research Capital LLC TRC lifted its holdings in shares of Intrexon by 2,031.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 5,180 shares of the biotechnology company’s stock worth $125,000 after acquiring an additional 4,937 shares during the period. SG Americas Securities LLC bought a new stake in shares of Intrexon during the 3rd quarter worth approximately $139,000. Federated Investors Inc. PA bought a new stake in shares of Intrexon during the 2nd quarter worth approximately $172,000. Finally, Quantbot Technologies LP lifted its holdings in shares of Intrexon by 423.7% during the 3rd quarter. Quantbot Technologies LP now owns 9,993 shares of the biotechnology company’s stock worth $189,000 after acquiring an additional 8,085 shares during the period. Hedge funds and other institutional investors own 77.45% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/intrexon-xon-shares-up-16-9/1792238.html.

Intrexon Company Profile

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

Receive News & Ratings for Intrexon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon and related companies with MarketBeat.com's FREE daily email newsletter.